Advanced search
Publication Cover
OncoImmunology Volume 6, 2017 - Issue 12
Submit an article Journal homepage
3,887
Views
27
CrossRef citations to date
0
Altmetric
Review

Trial watch: DNA-based vaccines for oncological indications

Stefano PieriniDepartment of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA;Ovarian Cancer Research Center (OCRC), Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
,
Renzo Perales-LinaresDepartment of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA;Ovarian Cancer Research Center (OCRC), Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
,
Mireia Uribe-HerranzDepartment of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA;Ovarian Cancer Research Center (OCRC), Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
,
Jonathan G. PolUniversité Paris Descartes/Paris V, France;Université Pierre et Marie Curie/Paris VI, Paris;Equipe 11 labellisée Ligue contre le Cancer, Centre de Recherche des Cordeliers, Paris, France;INSERM, Paris, France
,
Laurence ZitvogelGustave Roussy Comprehensive Cancer Institute, Villejuif, France;INSERM, Villejuif, France;Center of Clinical Investigations in Biotherapies of Cancer (CICBT), Villejuif, France;Université Paris Sud/Paris XI, Le Kremlin-Bicêtre, France
,
Guido KroemerUniversité Paris Descartes/Paris V, France;Université Pierre et Marie Curie/Paris VI, Paris;Equipe 11 labellisée Ligue contre le Cancer, Centre de Recherche des Cordeliers, Paris, France;INSERM, Paris, France;Metabolomics and Cell Biology Platforms, Gustave Roussy Comprehensive Cancer Institute, Villejuif, France;Karolinska Institute, Department of Women's and Children's Health, Karolinska University Hospital, Stockholm, Sweden;Pôle de Biologie, Hopitâl Européen George Pompidou, AP-HP; Paris, France
,
Andrea FacciabeneDepartment of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA;Ovarian Cancer Research Center (OCRC), Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USACorrespondence[email protected] [email protected]
&
Lorenzo GalluzziUniversité Paris Descartes/Paris V, France;Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA;Sandra and Edward Meyer Cancer Center, New York, NY, USACorrespondence[email protected] [email protected]
 show all
Article: e1398878 | Received 24 Oct 2017, Accepted 24 Oct 2017, Published online: 20 Nov 2017

Citations (27)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Alberto Cagigi & Bruno Douradinha. (2023) Have mRNA vaccines sentenced DNA vaccines to death?. Expert Review of Vaccines 22:1, pages 1154-1167.
Read now
Giorgio Frega, Qi Wu, Julie Le Naour, Erika Vacchelli, Lorenzo Galluzzi, Guido Kroemer & Oliver Kepp. (2020) Trial Watch: experimental TLR7/TLR8 agonists for oncological indications. OncoImmunology 9:1.
Read now
Sarah Lévesque, Julie Le Naour, Federico Pietrocola, Juliette Paillet, Margerie Kremer, Francesca Castoldi, Elisa E. Baracco, Yan Wang, Erika Vacchelli, Gautier Stoll, Ariane Jolly, Pierre De La Grange, Laurence Zitvogel, Guido Kroemer & Jonathan G. Pol. (2019) A synergistic triad of chemotherapy, immune checkpoint inhibitors, and caloric restriction mimetics eradicates tumors in mice. OncoImmunology 8:11.
Read now
Melody Smith, Elena García-Martínez, Michael R. Pitter, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial Watch: Toll-like receptor agonists in cancer immunotherapy. OncoImmunology 7:12.
Read now
Lucillia Bezu, Oliver Kepp, Giulia Cerrato, Jonathan Pol, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial watch: Peptide-based vaccines in anticancer therapy. OncoImmunology 7:12.
Read now
Elena García-Martínez, Melody Smith, Aitziber Buqué, Fernando Aranda, Francisco Ayala de la Peña, Alejandra Ivars, Manuel Sanchez Cánovas, Ma Angeles Vicente Conesa, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy. OncoImmunology 7:6.
Read now

Articles from other publishers (21)

Priyanshi Goyal & Rishabha Malviya. (2023) Advancement in Polymer-based Carrier for DNA Vaccine. Current Pharmaceutical Design 29:26, pages 2062-2077.
Crossref
Gul Naz Fatima, Hera Fatma & Shailendra K. Saraf. (2023) Vaccines in Breast Cancer: Challenges and Breakthroughs. Diagnostics 13:13, pages 2175.
Crossref
David C. Luther, Ritabrita Goswami, Yi-Wei Lee, Taewon Jeon, Rui Huang, James L. Elia, Harini Nagaraj, Jetta J. E. Bijlsma, Martin Piest, Martijn A. Langereis & Vincent M. Rotello. (2023) Non-viral vaccination through cationic guanidium polymer-pDNA polyplex mediated gene transfer. Nanoscale 15:24, pages 10351-10359.
Crossref
Hiroki Hayashi, Jiao Sun, Yuka Yanagida, Takako Otera, Ritsuko Kubota-Koketsu, Tatsuo Shioda, Chikako Ono, Yoshiharu Matsuura, Hisashi Arase, Shota Yoshida, Ryo Nakamaru, Nan Ju, Ryoko Ide, Akiko Tenma, Sotaro Kawabata, Takako Ehara, Makoto Sakaguchi, Hideki Tomioka, Munehisa Shimamura, Sachiko Okamoto, Yasunori Amaishi, Hideto Chono, Junichi Mineno, Takao Komatsuno, Yoshimi Saito, Hiromi Rakugi, Ryuichi Morishita & Hironori Nakagami. (2022) Preclinical study of a DNA vaccine targeting SARS-CoV-2. Current Research in Translational Medicine 70:4, pages 103348.
Crossref
Lana E. Kandalaft & Alexandre Harari. (2021) Vaccines as Priming Tools for T Cell Therapy for Epithelial Cancers. Cancers 13:22, pages 5819.
Crossref
Dalinda Eusébio, Ana R. Neves, Diana Costa, Swati Biswas, Gilberto Alves, Zhengrong Cui & Ângela Sousa. (2021) Methods to improve the immunogenicity of plasmid DNA vaccines. Drug Discovery Today 26:11, pages 2575-2592.
Crossref
J. Gutiérrez-Álvarez, J. M. HonrubiaA. Sanz-BravoE. González-MirandaR. Fernández-DelgadoM. T. Rejas, S. Zúñiga, I. Sola & L. Enjuanes. (2021) Middle East respiratory syndrome coronavirus vaccine based on a propagation-defective RNA replicon elicited sterilizing immunity in mice. Proceedings of the National Academy of Sciences 118:43.
Crossref
Raquel Cid & Jorge Bolívar. (2021) Platforms for Production of Protein-Based Vaccines: From Classical to Next-Generation Strategies. Biomolecules 11:8, pages 1072.
Crossref
Flavia Ferrantelli, Francesco Manfredi, Chiara Chiozzini, Patrizia Leone, Andrea Giovannelli, Eleonora Olivetta & Maurizio Federico. (2021) Long-Term Antitumor CD8+ T Cell Immunity Induced by Endogenously Engineered Extracellular Vesicles. Cancers 13:9, pages 2263.
Crossref
Juan Pablo Ortiz-Aguirre, Esteban Alejandro Velandia-Vargas, Oscar Mauricio Rodríguez-Bohorquez, Diego Amaya-Ramírez, David Bernal-Estévez & Carlos Alberto Parra-López. (2021) Inmunoterapia personalizada contra el cáncer basada en neoantígenos. Revisión de la literatura. Revista de la Facultad de Medicina 69:3, pages e81633.
Crossref
Stefano Pierini, Abhishek Mishra, Renzo Perales-Linares, Mireia Uribe-Herranz, Silvia Beghi, Andrea Giglio, Sergei Pustylnikov, Francesca Costabile, Stavros Rafail, Augusto Amici, John G Facciponte, Costantinos Koumenis & Andrea Facciabene. (2021) Combination of vasculature targeting, hypofractionated radiotherapy, and immune checkpoint inhibitor elicits potent antitumor immune response and blocks tumor progression. Journal for ImmunoTherapy of Cancer 9:2, pages e001636.
Crossref
Maria V. Stegantseva, Veronika A. Shinkevich, Elena M. Tumar & Alexander N. Meleshko. (2020) Multi-antigen DNA vaccine delivered by polyethylenimine and Salmonella enterica in neuroblastoma mouse model. Cancer Immunology, Immunotherapy 69:12, pages 2613-2622.
Crossref
Anne M. Macpherson, Simon C. Barry, Carmela Ricciardelli & Martin K. Oehler. (2020) Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy. Journal of Clinical Medicine 9:9, pages 2967.
Crossref
Stefano Pierini, Janos L. Tanyi, Fiona Simpkins, Erin George, Mireia Uribe-Herranz, Ronny Drapkin, Robert Burger, Mark A. Morgan & Andrea Facciabene. (2020) Ovarian granulosa cell tumor characterization identifies FOXL2 as an immunotherapeutic target. JCI Insight 5:16.
Crossref
I. V. Proleskovskaya, N. E. Konoplya & O. I. Bydanov. (2020) Treatment of relapse/progression of the disease in patients with neuroblastoma in the Republic of Belarus over a 20-year period: a cohort study. Russian Journal of Pediatric Hematology and Oncology 6:4, pages 40-47.
Crossref
Luigi Aurisicchio, Erika Salvatori, Lucia Lione, Silvio Bandini, Matteo Pallocca, Roberta Maggio, Maurizio Fanciulli, Francesca De Nicola, Frauke Goeman, Gennaro Ciliberto, Antonella Conforti, Laura Luberto & Fabio Palombo. (2019) Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth. Journal of Experimental & Clinical Cancer Research 38:1.
Crossref
Tadeja Forjanic, Bostjan Markelc, Marija Marcan, Elisabeth Bellard, Franck Couillaud, Muriel Golzio & Damijan Miklavci. (2019) Electroporation-Induced Stress Response and Its Effect on Gene Electrotransfer Efficacy: In Vivo Imaging and Numerical Modeling . IEEE Transactions on Biomedical Engineering 66:9, pages 2671-2683.
Crossref
Folarin, Nesbeth, Ward & Keshavarz-Moore. (2019) Application of Plasmid Engineering to Enhance Yield and Quality of Plasmid for Vaccine and Gene Therapy. Bioengineering 6:2, pages 54.
Crossref
Ilio Vitale, Antonella Sistigu, Gwenola Manic, Nils-Petter Rudqvist, Zlatko Trajanoski & Lorenzo Galluzzi. (2019) Mutational and Antigenic Landscape in Tumor Progression and Cancer Immunotherapy. Trends in Cell Biology 29:5, pages 396-416.
Crossref
Dominika Hobernik & Matthias Bros. (2018) DNA Vaccines—How Far From Clinical Use?. International Journal of Molecular Sciences 19:11, pages 3605.
Crossref
Hiroki Hayashi, jiao sun, Yuka Yanagida, Takako Ootera, Ritsuko Kubota-Koketsu, Tatsuo Shioda, Chikako Ono, Yoshiharu Matsuura, Hisashi Arase, Shota Yoshida, Ryo Nakamaru, Nan Ju, Ryoko Ide, Akiko Tenma, Sotaro Kawabata, Takako Ehara, Makoto Sakaguchi, Hideki Tomioka, Munehisa Shimamura, Sachiko Okamoto, Yasunori Amaishi, Hideto Chono, Junichi Mineno, Takao Komatsuno, Yoshimi Saito, Hiromi Rakugi, Ryuichi Morishita & Hironori Nakagami. (2021) Preclinical Study of DNA Vaccines Targeting SARS-CoV-2. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.